# FDA Inspection 1310554 - American Red Cross Blood Services - Southern Region - March 18, 2026

Source: https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services-southern-region/656b2e97-0b5c-40dd-87fc-7fa62bdf2393
Source feed: FDA_Inspections

> FDA Inspection 1310554 for American Red Cross Blood Services - Southern Region on March 18, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1310554
- Company Name: American Red Cross Blood Services - Southern Region
- Inspection Date: 2026-03-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1310554 - 2026-03-18](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services-southern-region/bb840778-d10f-4669-8fce-b2f0c7f11b3c)
- [FDA Inspection 1196915 - 2023-01-27](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services-southern-region/789b0bf8-e22f-4bff-9536-f59000c3124e)
- [FDA Inspection 1196915 - 2023-01-27](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services-southern-region/d091f451-b510-4dc3-aaf5-b5c158c3bdd0)
- [FDA Inspection 1038780 - 2018-01-10](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services-southern-region/6d20aa8c-a601-4778-bf19-7d83ba2bef40)
- [FDA Inspection 957698 - 2016-01-08](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services-southern-region/63373fc1-9949-4042-98f4-cfdcc157a92e)

Company: https://www.keypedia.com/companies/american-red-cross-blood-services-southern-region/6fb24b99-b430-4d3d-a0f1-29dd160c3157

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d